Search

everythinglearnresearchcommunity

for

Search:↓

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Finasteride use linked to increased suicidality in patients under 45.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

MED1 affects skin wound healing differently with age, speeding it up in young mice but slowing it in older mice.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Improving mesenchymal stromal cell therapies requires overcoming cell death and optimizing delivery methods.

Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.

Normal human melanocytes can avoid cell death through multiple pathways.

M1 homeopathic complex may help slow melanoma cell growth.

Mitochondriopathy may cause eyelash loss.

BMI1 is essential for preventing hair greying and maintaining hair color.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

The horse had a rare disease causing weight loss and skin issues, leading to euthanasia due to poor treatment options.

Advancements in regenerative science and longevity research can improve healthspans, but must be balanced with ethics and safety.

A 13-year-old boy with a rare genetic condition survived a heart attack and improved with treatment.

Gene therapy in mice increased lifespan and improved health without causing cancer.

Early diagnosis and proper treatment improve outcomes for methylmalonic acidemia.

The term "low-risk" in myelodysplastic syndrome is misleading and should be changed to better reflect patient experiences and needs.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Minoxidil treatment may cause hair loss.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

The model and estimator can predict drug exposure in kidney transplant patients well.